Choosing a course is one of the most important decisions you'll ever make! View our courses and see what our students and lecturers have to say about the courses you are interested in at the links below.
Each year more than 4,000 choose NUI Galway as their University of choice. Find out what life at NUI Galway is all about here.
About NUI Galway
About NUI Galway
Since 1845, NUI Galway has been sharing the highest quality teaching and research with Ireland and the world. Find out what makes our University so special – from our distinguished history to the latest news and campus developments.
Colleges & Schools
Colleges & Schools
NUI Galway has earned international recognition as a research-led university with a commitment to top quality teaching across a rang of key areas of expertise.
Business & Industry
Guiding Breakthrough Research at NUI Galway
We explore and facilitate commercial opportunities for the research community at NUI Galway, as well as facilitating industry partnership.
- Alumni, Friends & Supporters
At NUI Galway, we believe that the best learning takes place when you apply what you learn in a real world context. That's why many of our courses include work placements or community projects.
Room CRF 1.11
HRB Clinical Research Facility
T: 353 91 495308
Edel Murphy is the Development Officer for the HRB Irish Primary Care Clinical Trials Network. Edel holds a BSc from University College Dublin, an MSc in Cell Biology and the Higher Diploma in Education (NUI Galway). In 2012, she graduated with an MSc in Clinical Research from NUI Galway.
After a short spell teaching at second level, Edel had a successful career for a number of years in the technology industry, as an information designer/project manager and later, as an operations manager. She then ran her own project management company, managing a wide variety of projects for clients in the public, private and voluntary sectors.
Edel first worked as a research project manager with NUI Galway in 2005 and has since worked in a number of different disciplines within the University, including General Practice, the School of Nursing and Midwifery and Economics. Her research interests include dementia and palliative care, research methodology, with a particular interest in systematic reviews, and patient and public involvement in research.
In addition to her role on the HRB Irish Primary Care Clinical Trials Network, Edel currently holds a HRB Cochrane Fellowship (2013-2015) and is completing a systematic review on palliative care interventions in advanced dementia.
Edel most recently worked in the School of Business and Economics, managing the start-up of a national survey to establish the preferences of the public with regard to health and wellbeing. She previously worked on the SPHERE Follow-Up study, a 6 year follow-up to the original SPHERE study, a randomised controlled trial of tailored practice and patient care plans designed to improve outcomes for patients with coronary heart disease.
Edel is currently involved in a number of systematic reviews on different topics, contributing systematic review expertise to the review teams.
Peer Reviewed Journals
|(2013)|| 'Developing a structured education reminiscence-based programme for staff in long-stay care facilities in Ireland'
Cooney, A. O’Shea, E. Casey, D. Murphy, K. Dempsey, L. Smyth, S. Hunter, A. Murphy, E. Devane, D. & Jordan, F. (2013) 'Developing a structured education reminiscence-based programme for staff in long-stay care facilities in Ireland'. Journal Of Clinical Nursing, 22 (13-14):1977-1987 [Details]
|(2011)|| 'Effectiveness of a structured education reminiscence-based programme for staff on the quality of life of residents with dementia in long-stay units: A study protocol for a cluster randomised trial'
O'Shea, E.,Devane, D.,Murphy, K.,Cooney, A.,Casey, D.,Jordan, F.,Hunter, A., Murphy, E. (2011) 'Effectiveness of a structured education reminiscence-based programme for staff on the quality of life of residents with dementia in long-stay units: A study protocol for a cluster randomised trial' Trials, 12 (41) . [Details]